Evaluation and validation of commercially available enzyme-linked immunosorbent assays (ELISAs) specific for atrazine, chlorpyrifos, and diazinon in aqueous phase

The performance of commercially available microtiter plate enzyme-linked immunosorbent assays (ELISA) kits specific for the determination of triazines (atrazine), chlorpyrifos, and diazinon was evaluated for sensitivity, intra-assay repeatability, and accuracy using samples of known concentration in aqueous solution. Mean percent recovery values were not significantly different among concentrations for diazinon (One-way parametric ANOVA, P=0.46, n=72). However, mean percent recovery values were significantly different among concentrations for both atrazine and chlorpyrifos analyses (One-way parametric ANOVA, P<0.0001, n=36 for both analyses), and were highly dependent on concentrations for chlorpyrifos (% recovery=−0.155 (concentration)+238.448, r2=0.91, P<0.0001, n=36). All methods demonstrated a high degree of statistical separation between readings at various concentrations (One-way parametric ANOVA followed by Student–Neuman–Keuls (SNK) multiple range test, P<0.0001 for all analyses) and a close correlation between known concentrations and concentrations derived from ELISA for all three analytes (diazinon, r=0.985, P<0.0001, n=72; atrazine r=0.967, P<0.0001, n=36; chlorpyrifos r=0.947, P<0.0001, n=36). Statistical comparisons between known concentrations and concentrations derived from ELISAs showed that diazinon values were significantly (P<0.01, n=12 per concentration level) overestimated for all concentration levels. Chlorpyrifos concentrations were significantly (P<0.01, n=6 per concentration level) overestimated at lower concentrations and significantly (P<0.01, n=6 per concentration level) underestimated at higher concentrations. ELISA-derived atrazine concentrations were statistically similar to known concentrations for most concentration levels (P>0.05, n=6 per concentration level). Results indicate that ELISA kits are excellent for screening purposes, although consistent overestimation of ELISA for diazinon at all concentration levels and chlorpyrifos at lower concentrations levels must be resolved before the kits can be used routinely for regulatory compliance monitoring.